This compound is a sulfonamide derivative used as a pharmaceutical intermediate in the manufacturing of bosentan-related compounds. It features a complex aromatic structure containing ether and halogen functional groups.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 150727-06-3
Bosentan hydrate
pharmaceutical raw material
4-(tert-Butyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl)benzenesulfonamide hydrochloride
pharmaceutical raw material
Bosentan
pharmaceutical raw material
4,6-Dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine
pharmaceutical intermediate
O1-tert-butyl O3-ethyl cis-4-hydroxypiperidine-1,3-dicarboxylate
pharmaceutical intermediate
5'-O-(4,4-Dimethoxytrityl)-2'-O-methyl-N-isobutyrylguanosine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite
pharmaceutical intermediate
2-Ethoxycarbonylamino-5-(4-fluorobenzylamino)nitrobenzene
pharmaceutical intermediate
4-tert-butyl-N-[6-chloro-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide
XKISWHVJIZSPSC-UHFFFAOYSA-N
CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)Cl)OC4=CC=CC=C4OC